Alan Auerbach Overview

  • Investor Type
  • Angel

Alan Auerbach General Information


Mr. Alan Auerbach serves as Chief Executive Officer, President and Chairman of the Board at Puma Biotechnology. He has served as our Chairman of the Board and as our Chief Executive Officer and President since our inception. Prior to founding Puma, he served as Founder, Chief Executive Officer, President and a Member of the Board of Directors of Cougar Biotechnology, from the company's inception in 2003 until its acquisition by Johnson & Johnson in July 2009. From July 2009 until January 2010, he served as Co-Chairman of the Integration Steering Committee at Cougar (as part of Johnson & Johnson) and provided leadership and oversight for the development and global commercialization of Cougar's lead product candidate, abiraterone acetate. Abiraterone was approved for the treatment of metastatic prostate cancer in the U.S. in April 2011 and in the European Union in September 2011. Prior to founding Cougar, from June 1998 to April 2003, he was Vice President, Senior Research Analyst at Wells Fargo Securities, where he was responsible for research coverage of small- and middle-capitalization biotechnology companies, with a focus on companies in the field of oncology. He had primary responsibility for technical, scientific and clinical due diligence, as well as a selection of biotechnology companies followed by the company. In 2002, he ranked second in the NASDAQ/Starmine survey of analyst performance for stock picking in biotechnology. From August 1997 to May 1998, he was a Vice President and research Analyst at the Seidler Companies, where he was responsible for research coverage of small-capitalization biotechnology companies. Prior to his work as a biotechnology analyst, he worked for Diagnostic Products Corporation, where he designed and implemented clinical trials in the field of oncology. He received a B.S. in Biomedical Engineering from Boston University and an M.S. in Biomedical Engineering from the University of Southern California.

Business Details

Primary Investor Type
Angel (individual)
Corporate Office
  • Los Angeles, CA
  • United States

Alan Auerbach Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Alan Auerbach Team (1)

Name Title Deals Funds Boards Office
Alan Auerbach Angel Investor 0 0 Los Angeles, CA

Alan Auerbach FAQs

  • Who is Alan Auerbach?

    Alan Auerbach is an angel Investor who has made 0 investments.

  • What kind of investor is Alan Auerbach?

    Alan Auerbach is an angel investor.

  • What does Alan Auerbach do?

    As an angel investor, Alan Auerbach invests personal money into promising companies, typically in exchange for equity.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »